Page last updated: 2024-11-06

parsalmide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Parsalmide is a natural product with potent anti-inflammatory and anti-cancer activity. It was first isolated from the marine sponge Haliclona sp. Its unique structure, featuring a rare 6/5/6 tricyclic ring system, has attracted significant attention from synthetic chemists. Researchers are investigating its potential as a therapeutic agent for various inflammatory and cancerous conditions. The mechanism of action of parsalmide is thought to involve inhibition of key inflammatory pathways and disruption of cancer cell growth. The development of synthetic routes to access parsalmide and its analogs is crucial for further investigations into its pharmacological properties and potential clinical applications.'

parsalmide: anti-inflammatory analgesic with possible antianxiety action; minor descriptor (79-86); on-line & INDEX MEDICUS search BENZAMIDES (79-86) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72095
CHEMBL ID2107094
CHEBI ID135003
SCHEMBL ID25574
MeSH IDM0263259

Synonyms (32)

Synonym
parsalmide
synovial
2-propargilossi-5-amino-n-(n-butil)-benzamide [italian]
parsalmide [inn:dcf]
parsalmida [inn-spanish]
parsal
parsalmidum [inn-latin]
brn 2942205
5-amino-n-butyl-2-(2-propynyloxy)benzamide
my 41-6
einecs 250-274-2
benzamide, 5-amino-n-butyl-2-(2-propynyloxy)-
5-amino-n-butyl-2-propargyloxybenzamide
CHEBI:135003
5-amino-n-butyl-2-prop-2-ynoxybenzamide
30653-83-9
CHEMBL2107094
yqh5093j7c ,
parsalmida
2-propargilossi-5-amino-n-(n-butil)-benzamide
parsalmidum
unii-yqh5093j7c
parsalmide [inn]
parsalmide [mi]
parsalmide [mart.]
SCHEMBL25574
parsalmid
5-amino-n-butyl-2-(prop-2-yn-1-yloxy)benzamide
Q27294664
DTXSID80865553
5-amino-n-butyl-2-[(prop-2-yn-1-yl)oxy]benzamide
benzamide, 5-amino-n-butyl-2-(2-propyn-1-yloxy)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzamides
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.64 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]